LETROZOLE (Femara) ALVOGEN 2.5 mg – 30 Tablets

Letrozole (Femara) ALVOGEN 2.5 mg is an aromatase inhibitor containing 2.5 mg of letrozole per tablet. It is primarily used in the treatment of hormone receptor-positive breast cancer in postmenopausal women by reducing estrogen production in the body. Each pack contains 30 film-coated tablets and is manufactured to high pharmaceutical quality standards by Alvogen, ensuring reliability, efficacy, and patient safety.